Global Drug Delivery Technology Market, By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), Facility of Use (Hospitals, Ambulatory Surgical Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Drug Delivery Technology
Drug delivery technology market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 7.65% in the above-mentioned forecast period.
Drug delivery is basically the procedure to administer therapeutic substance through common route of administration to achieve a therapeutic effect in humans or animals. The drugs delivery technology controls the rate and time of the drug released in the body thus improving the efficacy of the drug.
The growing cases and prevalence of chronic diseases and large patient pools across the globe is the significant factor responsible for driving the growth of the drug delivery technology market in the above-mentioned forecast period. Additionally, the factors such as increasing number of clinical trials, rising investments by key players in this region and low labor costs also heighten the overall growth of the market. However, the side effect of drugs and recalling of products obstruct the market’s growth. The risk of needle-stick injuries and side effects are also estimated to be the restraint that will hamper the overall growth of the market.
The launch of advanced new products and advancement in technologies are expected to generate profitable opportunities for the market. On the other hand, the dearth of skilled professionals have the potential to challenge for the market’s growth.
This drug delivery technology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research drug delivery technology market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Drug Delivery Technology Market Scope and Market Size
Drug delivery technology market is segmented on the basis of route of administration and facility of use. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on route of administration, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, ocular drug delivery, nasal drug delivery, topical drug delivery implantable drug delivery and transmucosal drug delivery. The oral drug delivery is sub-segmented into solid oral drugs, liquid oral drugs and semi-solid oral drugs. The solid oral drugs are sub segmented into tablets, capsules, powders and pills. The liquid oral drugs are sub segmented into solutions and syrups. The semi-solid oral drugs are further sub segmented into gels, emulsions and elixirs. The pulmonary drug delivery is sub-segmented into formulations and devices. The devices are further sub segmented into metered dose inhalers, dry powder inhalers and nebulizers. The nebulizers are sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers. The injectable drug delivery is sub-segmented into devices, self-injection devices and other injector devices. The conventional injection devices are sub segmented into material, glass, plastic, product and usability. The product is segmented into fillable syringes and prefilled syringes. The usability is segmented into reusable syringes and disposable syringes. The self-injection devices are sub segmented into needle-free injectors, autoinjectors, pen injectors and wearable injectors. The formulations are divided into conventional drug delivery, novel drug delivery formulations and long-acting injection formulations. The ocular drug delivery is sub-segmented into formulations and ocular devices. The formulations are further sub divided into liquid formulations and semi-solid formulations. The liquid formulations are divided into eye drops and liquid sprays. The semi-solid formulations consist of gels and eye ointments. The ocular devices consist of drug-coated contact lenses and ocular inserts. The nasal drug delivery is sub-segmented into nasal drops, nasal sprays, nasal powders and nasal gels. Under topical drug delivery it is segmented into formulations and devices (transdermal drug delivery). The formulations liquid is sub- segmented into topical drug delivery, semi-solid topical drug delivery and solid topical drug delivery. The liquid topical drug delivery is again sub segmented into solutions and suspensions. The semi-solid topical drug delivery is sub-segmented into creams, gels, ointments, pastes and lotions. The solid topical drug delivery is segmented into suppositories and powders. The devices are sub-segmented into transdermal patches and transdermal gels. Implantable drug delivery is sub-segmented into active implantable drug delivery and passive implantable drug delivery. The transmucosal drug delivery is sub-segmented into oral transmucosal drug delivery and other transmucosal drug delivery. The oral transmucosal drug delivery is further sub-segmented into buccal drug delivery and sublingual drug delivery whereas the other transmucosal drug delivery is further sub-segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
- On the basis of facility of use, the global drug delivery technology market is segmented into hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers and other facilities of use.
Drug Delivery Technology Market Country Level Analysis
Drug delivery technology market is analyzed and market size insights and trends are provided by route of administration and facility of use as referenced above.
The countries covered in the drug delivery technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the high prevalence of chronic diseases such as cancer, cardio vascular diseases, diabetes, respiratory diseases and ongoing technological advancements in drug delivery technology in the region. Asia-Pacific, on the other hand is expected to show a rapid and lucrative growth rate in the forecast period owing to the funds allocated by top companies in the field of R&D activities along with low prices of clinical trials and labor.
The country section of the drug delivery technology market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Drug delivery technology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for drug delivery technology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug delivery technology market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Drug Delivery Technology Market Share Analysis
Drug delivery technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug delivery technology market.
Some of the major players operating in the drug delivery technology market report are Johnson & Johnson Private Limited ., F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp., Bayer AG, Pfizer Inc, Novartis AG, 3M, BD, GlaxoSmithKline plc., Sanofi, Antares Pharma, generex, EyePoint Pharmaceuticals Inc., Alkermes., Vectura Group plc, NanoPass, Baxter, AstraZeneca, and Takeda Pharmaceutical Company Limited among others.
SKU-